Applications for Leave

Decision Information

Decision Content

No. 39007     

 

 

May 7, 2020

 

Le 7 mai 2020

 

 

 

BETWEEN:

Millennium Pharmaceuticals Inc., Janssen Inc., Cilag GMBH International, Cilag AG and Janssen Pharmaceutica NV

Applicants

- and -

Teva Canada Limited and the United States of America Represented by the Department of Health and Human Services

Respondents

 

ENTRE :

Millennium Pharmaceuticals Inc., Janssen Inc., Cilag GMBH International, Cilag AG

et Janssen Pharmaceutica NV

Demanderesses

- et -

Teva Canada Limitée et les États-Unis d’Amérique représentés par le Department of Health and Human Services



Intimés

 

 

 

JUDGMENT

 

The application for leave to appeal from the judgment of the Federal Court of Appeal, Number A-301-18, 2019 FCA 273, dated November 4, 2019, is dismissed with costs.

 

 

 

JUGEMENT

 

La demande d’autorisation d’appel de l’arrêt de la Cour d’appel fédérale, numéro A-301-18, 2019 FCA 273, daté du 4 novembre 2019, est rejetée avec dépens.

 

 

 

 

C.J.C.

J.C.C.

 

 You are being directed to the most recent version of the statute which may not be the version considered at the time of the judgment.